Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Central versus peripheral epinephrine administration during cardiopulmonary resuscitation
IRCT20180613040087N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of epinephrine in cardiac arrest (SCA) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Systolic blood pressure after return of spontaneous circulation, Diastolic blood pressure after return of spontaneous circulation and 2 more. Started Feb 2019; status: completed.
02
Drugs
epinephrine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on IRCT20180613040087N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180613040087N2.